A New Possible Cut-Off of Cytokeratin 19 mRNA Copy Number by OSNA in the Sentinel Node of Breast Cancer Patients to Avoid Unnecessary Axillary Dissection: A 10-Year Experience in a Tertiary Breast Unit.
Giovanni TomasicchioMauro Giuseppe MastropasquaArcangelo PicciarielloAlda Elena MontanaroDaniela SignorileAlfredo CirilliClelia PunzoPublished in: Cancers (2022)
(1) Background: The main discriminant in breast cancer prognosis is axillary lymph node status. In a select cohort of patients, axillary lymph node dissection (ALND) may be safely spared. This study aimed to determine a new possible cut-off of cytokeratin (CK) 19 mRNA copy number in the SLN to predict cases at high risk of positive ALND. (2) Methods: Clinical records of 1339 patients were retrospectively reviewed and were separated into two groups according to the axillary status (negative: ALNs- and positive ALNs+). Receiver operative characteristic (ROC) curves were used to identify a new optimal cut-off of CK19 mRNA copy number in SLN; (3) Results: Large tumor size and high grade were found mostly in ALNs+. Results from the ROC analyses, with an AUC of 82.1%, identified a new cut-off (9150 CK19 mRNA copies) showing 94% sensitivity, 67.3% specificity, 61.2% positive, and 95.3% negative predictive values; (4) OSNA remains the most-important intra-operative tool to identify patients who can benefit from ALND but with the traditional cut-off, many patients undergo needless ALND. The results of the present study suggest a new cut-off helpful to personalize surgical treatment and avoid unnecessary invasive procedures.
Keyphrases
- copy number
- lymph node
- mitochondrial dna
- end stage renal disease
- sentinel lymph node
- ejection fraction
- chronic kidney disease
- newly diagnosed
- genome wide
- neoadjuvant chemotherapy
- high grade
- prognostic factors
- peritoneal dialysis
- prostate cancer
- gene expression
- patient reported outcomes
- low grade
- early stage
- radiation therapy
- spinal cord injury
- locally advanced